DiaMedica Therapeutics Inc • DMAC

Capital at risk.

About DiaMedica Therapeutics Inc
Ticker
info
DMAC
Trading on
info
NASDAQ
ISIN
info
CA25253X2077
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dietrich John Pauls MBA
Headquarters
info
301 Carlson Parkway, Minneapolis, MN, United States, 55305
Employees
info
27
Website
info
diamedica.com
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Metrics
BasicAdvanced
Market cap
info
$155M
P/E ratio
info
-
EPS
info
-$0.64
Dividend Yield
info
0.00%
Beta
info
1.2
Forward P/E ratio
info
0
EBIDTA
info
$-29M
Ex dividend date
info
-
Price & volume
Market cap
info
$155M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
4.57
Earnings
EPS
info
-$0.64
EPS estimate (current quarter)
info
-$0.18
EPS estimate (next quarter)
info
-$0.18
EBITDA
info
$-29M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.2
52-week High
info
$6.82
52-week Low
info
$2.24
50-day moving average
info
$3.94
200-day moving average
info
$4.73
Short ratio
info
11.2
Short %
info
4.07%
Management effectiveness
ROE (TTM)
info
-67.25%
ROA (TTM)
info
-41.27%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
42.9M
Float
info
24.3M
Insiders %
info
15.65%
Institutions %
info
36.00%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 4 analysts.

Average price target

info
$9.67
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.13
-$0.16
18.75%
Q2 • 24Beat
-$0.15
-$0.15
-
Q3 • 24Beat
-$0.18
-$0.17
-4.35%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-7.9M
-∞%
Q4 • 24
$0M
$-7.7M
-∞%
Q1 • 25
NaN%
-2.44%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$46.3M
$5.6M
12.14%
Q4 • 24
$38.8M
$4.9M
12.56%
Q1 • 25
-16.22%
-13.35%
3.42%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-6.4M
$5.2M
$0.1M
$-6.4M
Q4 • 24
$-7.1M
$6.6M
$0.1M
$-7.2M
Q1 • 25
11.11%
27.22%
-24.17%
11.18%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a DiaMedica Therapeutics Inc share?
Collapse

DiaMedica Therapeutics Inc shares are currently traded for undefined per share.

How many shares does DiaMedica Therapeutics Inc have?
Collapse

DiaMedica Therapeutics Inc currently has 42.9M shares.

Does DiaMedica Therapeutics Inc pay dividends?
Collapse

No, DiaMedica Therapeutics Inc doesn't pay dividends.

What is DiaMedica Therapeutics Inc 52 week high?
Collapse

DiaMedica Therapeutics Inc 52 week high is $6.82.

What is DiaMedica Therapeutics Inc 52 week low?
Collapse

DiaMedica Therapeutics Inc 52 week low is $2.24.

What is the 200-day moving average of DiaMedica Therapeutics Inc?
Collapse

DiaMedica Therapeutics Inc 200-day moving average is $4.73.

Who is DiaMedica Therapeutics Inc CEO?
Collapse

The CEO of DiaMedica Therapeutics Inc is Dietrich John Pauls MBA.

How many employees DiaMedica Therapeutics Inc has?
Collapse

DiaMedica Therapeutics Inc has 27 employees.

What is the market cap of DiaMedica Therapeutics Inc?
Collapse

The market cap of DiaMedica Therapeutics Inc is $155M.

What is the P/E of DiaMedica Therapeutics Inc?
Collapse

The current P/E of DiaMedica Therapeutics Inc is null.

What is the EPS of DiaMedica Therapeutics Inc?
Collapse

The EPS of DiaMedica Therapeutics Inc is -$0.64.

What is the PEG Ratio of DiaMedica Therapeutics Inc?
Collapse

The PEG Ratio of DiaMedica Therapeutics Inc is null.

What do analysts say about DiaMedica Therapeutics Inc?
Collapse

According to the analysts DiaMedica Therapeutics Inc is considered a buy.